Salesforce Says Moderna Selects Agentforce Platform to Consolidate Commercial Operations

MT Newswires Live04-28 23:03

Salesforce (CRM) said Tuesday that Moderna (MRNA) has selected its Agentforce Life Sciences platform to consolidate commercial operations worldwide.

The platform will combine data, artificial intelligence, and customer interactions across multiple regions into a single system, Salesforce said.

The agreement allows the drugmaker to integrate information from different networks to generate real-time insights for cross-channel promotional campaigns, Salesforce said.

The software's open architecture will connect various operations to support Moderna in scaling without vendor restrictions, the company added.

Price: 182.49, Change: +2.31, Percent Change: +1.28

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment